Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring.

Amy HemperlyMarla C DubinskyAndres YarurAnita AfzaliStephen HanauerSubra KugathasanMillie D LongShervin RabizadehRobbyn SockolowLauren OkadaAnjali JainMaria T AbreuNiels Vande Casteele

Published in: Crohn's & colitis 360 (2021)

We report the anti-TNF concentration range associated with EHI <20. Combined testing of EHI and TDM is proposed as a noninvasive approach for treat-to-target management which could improve the ability to monitor disease and optimize anti-TNF therapy.

Keyphrases

rheumatoid arthritis
ultrasound guided
stem cells
drug delivery
cell therapy
smoking cessation
replacement therapy